evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's Nordisk: Intense Competition Within GLP-1 Duopoly (NYSE:NVO) StockWatch: Lilly Narrows GLP-1 Revenue
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16





























